Quick Answer
enVVeno Medical Corp reported Total Assets of $29.56 million for the year ending 2025.
- enVVeno Medical Corp showed a decrease of -34.2% in Total Assets from 2024 to 2025.
- This data is from enVVeno Medical Corp's annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2018: $7.21 million | Q3 2018: $5.44 million | Q1 2019: $5.49 million | Q2 2019: $7.25 million | Q3 2019: $5.75 million | Q1 2020: $2.77 million | Q2 2020: $3.73 million | Q3 2020: $7.04 million | Q1 2021: $45.05 million | Q2 2021: $42.35 million | Q3 2021: $59.17 million | Q1 2022: $54.22 million | Q2 2022: $49.93 million | Q3 2022: $45.46 million | Q1 2023: $36.61 million | Q2 2023: $32.09 million | Q3 2023: $28.09 million | Q1 2024: $44.83 million | Q2 2024: $41.00 million | Q3 2024: $50.39 million | Q1 2025: $40.58 million | Q2 2025: $36.58 million | Q3 2025: $32.35 million.
- Over the full 9 years of available data (2017 to 2025), enVVeno Medical Corp's Total Assets has grown by 1,234.7%.
- Historical annual values: Fiscal year 2025: $29.56 million | Fiscal year 2024: $44.95 million | Fiscal year 2023: $48.64 million | Fiscal year 2022: $41.66 million | Fiscal year 2021: $57.70 million | Fiscal year 2020: $10.54 million | Fiscal year 2019: $3.43 million | Fiscal year 2018: $3.56 million | Fiscal year 2017: $2.21 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: